Barclays
IPXL

Barclays’s Impax Laboratories, Inc. IPXL Stock Holding History

Barclays’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,000
Closed -$223K – 7296
2017
Q3 		$223K Buy
+11,000
New +$210K ﹤0.01% 4337
2016
Q3 		– Sell
-582,200
Closed -$16.8M – 6944
2016
Q2 		$16.8M Buy
+582,200
New +$19M 0.02% 592

Barclays's IPXL Position: Q2 2018 in Review

Barclays sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 164,104 shares — an estimated $3.19M sold.

Barclays first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $3.64M in Q4 2014. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • Barclays reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • Barclays sold 164,104 Impax Laboratories, Inc. shares in Q2 2018, an estimated $3.19M.
  • Barclays first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
  • Barclays's Impax Laboratories, Inc. position peaked at $3.64M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.